33290860|t|Restoration of BMI1 levels after the administration of early harvest extra virgin olive oil as a therapeutic strategy against Alzheimer's disease.
33290860|a|Even though Alzheimer's disease (AD) is the most common cause of dementia, the mechanisms governing the establishment and progression of the disease remain largely unknown. Here, we investigated the implication of the neuroprotective protein BMI1 (B lymphoma Mo-MLV insertion region 1 homolog) in AD and the possibility to reverse the onset of the disease through the administration of extra virgin olive oil (EVOO) in Mild Cognitive Impairment (MCI) patients. For this purpose, we utilized a wide bank of MCI patient samples to examine the potential effects of EVOO. We found that while EVOO treatment increases BMI1 levels, p53 levels drop in MCI patient serum after EVOO treatment for 12 months. Additionally, AD-related biomarkers (p-tau, Abeta1-42 and Abeta1-42/Abeta-40 ratio) return to normal levels after administration of EVOO in MCI patients for 12 months. Moreover, we show that upon EVOO administration, BMI1-upregulation correlates with reduction of oxidative stress and inflammatory responses. In conclusion, we provide clinical trial evidence to confirm that restoration of BMI1 activity through EVOO administration in MCI patients constitutes a potential therapeutic approach against neurodegeneration leading to AD.
33290860	15	19	BMI1	Gene	648
33290860	69	91	extra virgin olive oil	Chemical	-
33290860	126	145	Alzheimer's disease	Disease	MESH:D000544
33290860	159	178	Alzheimer's disease	Disease	MESH:D000544
33290860	180	182	AD	Disease	MESH:D000544
33290860	212	220	dementia	Disease	MESH:D003704
33290860	389	393	BMI1	Gene	648
33290860	444	446	AD	Disease	MESH:D000544
33290860	533	555	extra virgin olive oil	Chemical	-
33290860	557	561	EVOO	Chemical	-
33290860	571	591	Cognitive Impairment	Disease	MESH:D003072
33290860	593	596	MCI	Disease	MESH:D060825
33290860	598	606	patients	Species	9606
33290860	653	656	MCI	Disease	MESH:D060825
33290860	657	664	patient	Species	9606
33290860	709	713	EVOO	Chemical	-
33290860	735	739	EVOO	Chemical	-
33290860	760	764	BMI1	Gene	648
33290860	773	776	p53	Gene	7157
33290860	792	795	MCI	Disease	MESH:D060825
33290860	796	803	patient	Species	9606
33290860	816	820	EVOO	Chemical	-
33290860	860	862	AD	Disease	MESH:D000544
33290860	885	888	tau	Gene	4137
33290860	978	982	EVOO	Chemical	-
33290860	986	989	MCI	Disease	MESH:D060825
33290860	990	998	patients	Species	9606
33290860	1042	1046	EVOO	Chemical	-
33290860	1063	1067	BMI1	Gene	648
33290860	1131	1143	inflammatory	Disease	MESH:D007249
33290860	1236	1240	BMI1	Gene	648
33290860	1258	1262	EVOO	Chemical	-
33290860	1281	1284	MCI	Disease	MESH:D060825
33290860	1285	1293	patients	Species	9606
33290860	1347	1364	neurodegeneration	Disease	MESH:D019636
33290860	1376	1378	AD	Disease	MESH:D000544
33290860	Association	MESH:D000544	648
33290860	Association	MESH:D000544	4137
33290860	Association	MESH:D060825	7157
33290860	Negative_Correlation	MESH:D007249	648

